Gene · 435
Papers1,794
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,794
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma. | Front Oncol | 2022 | 36582804 | PubTator, text mining | PubMed |
| Wild Watermelon-Extracted Juice Ingestion Reduces Peripheral Arterial Stiffness with an Increase in Nitric Oxide Production: A Randomized Crossover Pilot Study. | Nutrients | 2022 | 36558358 | PubTator, text mining | PubMed |
| Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients. | Diagnostics (Basel) | 2022 | 36553008 | PubTator, text mining | PubMed |
| Growth hormone treatment improves final height in children with X-linked hypophosphatemia. | Orphanet J Rare Dis | 2022 | 36544157 | PubTator, text mining | PubMed |
| Hyperammonemia in a pregnant woman with citrullinemia type I: a case report and literature review. | BMC Pregnancy Childbirth | 2022 | 36536326 | PubTator, text mining | PubMed |
| Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1. | Stem Cells Int | 2022 | 36530488 | PubTator, text mining | PubMed |
| Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice. | Drug Des Devel Ther | 2022 | 36510490 | PubTator, text mining | PubMed |
| Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas. | Mol Cell | 2022 | 36459985 | PubTator, text mining | PubMed |
| Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity. | Cancer Metab | 2022 | 36457136 | PubTator, text mining | PubMed |
| Application of machine learning model to predict lacunar cerebral infarction in elderly patients with femoral neck fracture before surgery. | BMC Geriatr | 2022 | 36443675 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. | Int J Mol Sci | 2022 | 36430837 | PubTator, text mining | PubMed |
| Durability and corrosion behaviors of superhydrophobic amorphous coatings: a contrastive investigation. | RSC Adv | 2022 | 36425175 | PubTator, text mining | PubMed |
| Predictive markers for efficiency of the amino-acid deprivation therapies in cancer. | Front Med (Lausanne) | 2022 | 36405587 | PubTator, text mining | PubMed |
| Ensuring Equitable Access to the COVID-19 Vaccine: The Experience of A Local Health Unit in Rome, Italy. | Healthcare (Basel) | 2022 | 36360587 | PubTator, text mining | PubMed |
| Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism. | Cells | 2022 | 36359738 | PubTator, text mining | PubMed |
| Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer. | Biomolecules | 2022 | 36358940 | PubTator, text mining | PubMed |
| Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy. | Cancers (Basel) | 2022 | 36358687 | PubTator, text mining | PubMed |
| Protocol for large scale whole blood immune monitoring by mass cytometry and Cyto Quality Pipeline. | STAR Protoc | 2022 | 36353363 | PubTator, text mining | PubMed |
| Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients. | Front Immunol | 2022 | 36341434 | PubTator, text mining | PubMed |
| Are palm reversals the pronoun reversals of sign language? Evidence from a fingerspelling task. | Front Psychol | 2022 | 36312121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/435/papers?page=13